Charles Schwab Investment Management Inc Seelos Therapeutics, Inc. Transaction History

Charles Schwab Investment Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	BUY	$0.16 - $1.64 $9,633 - $98,741	60,208 Added 153.8%	99,356 $17,000
Q2 2022 Aug 15, 2022	SELL	$0.51 - $0.93 $115,023 - $209,748	-225,536 Reduced 85.21%	39,148 $27,000
Q1 2022 May 13, 2022	BUY	$0.84 - $1.71 $15,964 - $32,498	19,005 Added 7.74%	264,684 $222,000
Q3 2021 Nov 16, 2021	BUY	$1.69 - $2.89 $77,337 - $132,252	45,762 Added 22.89%	245,679 $593,000
Q2 2021 Aug 16, 2021	BUY	$2.64 - $6.32 $462,963 - $1.11 Million	175,365 Added 714.26%	199,917 $528,000
Q1 2021 May 17, 2021	BUY	$1.35 - $4.99 $33,145 - $122,514	24,552 New	24,552 $123,000

40.5K

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $117M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.